ENDONOVO THERAPEUTICS, INC. (ENDV)
About ENDONOVO THERAPEUTICS, INC.
NDONOVO THERAPEUTICS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2022
- $135.4K
- Net income
- -$18.5M
- Total assets
- $1.3M
Source: SEC EDGAR · updated Jun 8, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Endonovo Therapeutics, Inc. (ENDV) Stock Price
- Reported a net loss of $18.5M in FY2022.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ENDONOVO THERAPEUTICS, INC..
Write a review
Endonovo Therapeutics, Inc.: frequently asked questions
Is Endonovo Therapeutics, Inc. an American company?
Endonovo Therapeutics, Inc. is a US-based company headquartered in Woodland Hills, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Endonovo Therapeutics, Inc. headquartered?
Endonovo Therapeutics, Inc. is headquartered in Woodland Hills, California, United States.
Is Endonovo Therapeutics, Inc. publicly traded?
Yes — Endonovo Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ENDV on the OTC.
What does Endonovo Therapeutics, Inc. do?
Endonovo Therapeutics, Inc. is an American Medical Devices company in the Health & Beauty sector.
